Skip to main content

Eventide Asset Management, LLC

SEC CIK
0001442891
Latest filing
Aug 14, 2026

APGE holding history

Apogee Therapeutics, Inc. in every 13F filed by Eventide Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APGE overviewAll 13F holders of APGEFull Q2 2026 holdings

Shares (Q2 2026)
260,000
Value
$34.5M
% of portfolio
0.5%
Quarters held
3
Since Q4 2025
Holdings of APGE by Eventide Asset Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026260,000$34.5M0.5%−297,423−53.4%ReducedHolders
Q1 2026557,423$46.9M0.8%+121,408+27.8%AddedHolders
Q4 2025436,015$32.9M0.5%+436,015NewHolders